DGIdb - ESR2 Gene Record

ESR2 2100 Druggable Genome

Alternate Names:

ESR2
2100
ESTROGEN RECEPTOR 2
ER-BETA
ESR-BETA
ESRB
ESTRB
Erb
NR3A2
601663
3468
ENSG00000140009
OTTHUMG00000141306
Q92731
ESTROGEN RECEPTOR BETA (ER-BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q92731]
ESTROGEN RECEPTOR BETA
ESR2_HUMAN
PA27886
Nuclear receptor subfamily 3 group A member 2
T80896
ODG8

Gene Info:

Target Class	Receptors
Target Subclass	Nuclear receptor
Human Readable Name	DRUGGABLE GENOME
Initial Gene Query	NR3A2
Counted Citations from 1950-2000	3987
Interpro Name	Nuclear hormone receptor, ligand-binding, core
Human Readable Name	NUCLEAR HORMONE RECEPTOR
Interpro Type	Domain
Uniprot Status	Swiss-Prot
Interpro Acc	IPR000536
Interpro Short Name	Nucl_hrmn_rcpt_lig-bd_core
Uniprot Evidence	1: Evidence at protein level
Target Main Class	Receptors
Gene Biotype	PROTEIN_CODING

(11 More Sources)

Gene Categories: Category Details

NUCLEAR HORMONE RECEPTOR
DRUGGABLE GENOME
TRANSCRIPTION FACTOR

Publications:

Mc Ilroy et al., 2006, Tamoxifen-induced ER-alpha-SRC-3 interaction in HER2 positive human breast cancer; a possible mechanism for ER isoform specific recurrence., Endocr. Relat. Cancer
Girault et al., 2006, Role of estrogen receptor alpha transcriptional coregulators in tamoxifen resistance in breast cancer., Maturitas
Hayes et al., 2010, Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results., Clin. Pharmacol. Ther.
Sasson, 1991, Equilibrium binding analysis of estrogen agonists and antagonists: relation to the activation of the estrogen receptor., Pathol. Biol.
Chen et al., 2005, Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex., Int. J. Oncol.
Gruvberger-Saal et al., 2007, Estrogen receptor beta expression is associated with tamoxifen response in ERalpha-negative breast carcinoma., Clin. Cancer Res.
Chen et al., 2002, TTD: Therapeutic Target Database., Nucleic Acids Res.
Horner-Glister et al., 2005, Influence of oestradiol and tamoxifen on oestrogen receptors-alpha and -beta protein degradation and non-genomic signalling pathways in uterine and breast carcinoma cells., J. Mol. Endocrinol.
Ntukidem NI et al., 2008, Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen., Clin Pharmacol Ther
Jain D et al., 2010, A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements., Bioorg Med Chem Lett
Overington et al., 2006, How many drug targets are there?, Nat Rev Drug Discov
Imming et al., 2006, Drugs, their targets and the nature and number of drug targets., Nat Rev Drug Discov
Berman et al., 2000, The Protein Data Bank., Nucleic Acids Res.
Min J et al., 2013, Thiophene-core estrogen receptor ligands having superagonist activity., J Med Chem
Komm BS et al., 2005, Bazedoxifene acetate: a selective estrogen receptor modulator with improved selectivity., Endocrinology
Zhou et al., 2002, Selective estrogen receptor modulator effects in the rat brain., Neuroendocrinology
Bryant et al., An estrogen receptor basis for raloxifene action in bone., J. Steroid Biochem. Mol. Biol.
Sun et al., 2002, Antagonists selective for estrogen receptor alpha., Endocrinology
Kim et al., 2002, Raloxifene, a selective estrogen receptor modulator, induces apoptosis in androgen-responsive human prostate cancer cell line LNCaP through an androgen-independent pathway., Cancer Res.
Iannone et al., 2001, Multiplexed molecular interactions of nuclear receptors using fluorescent microspheres., Cytometry
Bologa et al., 2006, Virtual and biomolecular screening converge on a selective agonist for GPR30., Nat. Chem. Biol.
Renner S et al., 2009, Bioactivity-guided mapping and navigation of chemical space., Nat Chem Biol
Vijayanathan et al., 2007, Effects of estradiol and 4-hydroxytamoxifen on the conformation, thermal stability, and DNA recognition of estrogen receptor beta., Biochem. Cell Biol.
Jiang Y et al., 2013, Mechanisms enforcing the estrogen receptor β selectivity of botanical estrogens., FASEB J
Paterni I et al., 2014, Estrogen receptors alpha (ERα) and beta (ERβ): subtype-selective ligands and clinical potential., Steroids
Calogeropoulou T et al., 2009, Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity., J Med Chem
Puddefoot et al., 2006, Trilostane in advanced breast cancer., Expert Opin Pharmacother
Barker et al., 2006, Comparison of effects of 4-hydroxy tamoxifen and trilostane on oestrogen-regulated gene expression in MCF-7 cells: up-regulation of oestrogen receptor beta., J. Steroid Biochem. Mol. Biol.
Puddefoot et al., 2002, Non-competitive steroid inhibition of oestrogen receptor functions., Int. J. Cancer
Woo HI et al., 2012, Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine., Pharmacogenomics
Setchell KD et al., 2005, S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora., Am J Clin Nutr
Mueller SO et al., 2004, Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells., Toxicol Sci
Oesterreich S et al., 2015, Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover., Breast Cancer Res Treat
Kuiper GG et al., 1998, Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta., Endocrinology
Reed et al., 2005, Dose-dependent effects of 4-hydroxytamoxifen, the active metabolite of tamoxifen, on estrogen receptor-alpha expression in the rat uterus., Anticancer Drugs

AUS-131 ESR2

Interaction Score: 5.07

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta agonist

Trial Name AUS-131

PMIDs:
15883431 15084758

Sources:
TdgClinicalTrial ChemblInteractions TTD
ERTEBEREL ESR2

Interaction Score: 3.04

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor beta agonist

Direct Interaction yes

PMIDs:
10592235

Sources:
ChemblInteractions TTD
PRINABEREL ESR2

Interaction Score: 3.04

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta agonist

PMIDs:
10592235

Sources:
ChemblInteractions TTD
MF101 ESR2

Interaction Score: 3.04

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name MF101 ,Menerba

Novel drug target Established target

Mechanism of Interaction Estrogen receptor beta agonist

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions TTD
CHEMBL1222035 ESR2

Interaction Score: 2.53

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
20659801 17139284 17016423 10592235

Sources:
DTC
CHEMBL2332580 ESR2

Interaction Score: 2.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
23586645

Sources:
DTC
MK-6913 ESR2

Interaction Score: 1.01

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

Trial Name MK-6913

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
ESTROGEN ESR2

Interaction Score: 1.01

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name conjugated estrogens/medroxyprogesterone acetate,Prempro, Premphase

Novel drug target Established target

Trial Name oral contraceptive,Pill-Plus

PMIDs:
None found

Sources:
TdgClinicalTrial TTD
FISPEMIFENE ESR2

Interaction Score: 1.01

Interaction Types & Directionality:

modulator

Interaction Info:

Trial Name fispemifene, HM-101

Novel drug target Established target

Mechanism of Interaction Estrogen receptor modulator

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
TRILOSTANE ESR2

Interaction Score: 0.68

Interaction Types & Directionality:

allosteric modulator

Interaction Info:

PMIDs:
17109615 16806905 12209583

Sources:
TTD
RALOXIFEN ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name Evista

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
ACOLBIFENE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

modulator

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor modulator

PMIDs:
None found

Sources:
ChemblInteractions
CHF4227 ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ESTROGENS, CONJUGATED SYNTHETIC A ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
DIETHYLSTILBESTROL DIPHOSPHATE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
SYNTHETIC CONJUGATED ESTROGENS, B ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ARZOXIFENE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
TTD
LY2245461 ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ESTROGENS, CONJUGATED ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
SR16234 ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name TAS-108

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial
SIVIFENE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name A-007

PMIDs:
None found

Sources:
TdgClinicalTrial
ESTRAMUSTINE PHOSPHATE SODIUM ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

modulator

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta

PMIDs:
None found

Sources:
ChemblInteractions
ESTROGENS, ESTERIFIED ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor agonist

PMIDs:
None found

Sources:
ChemblInteractions
BAZEDOXIFENE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name bazedoxifene, bazedoxifene/conjugated estrogens, TSE-424,Viviant, Aprela, Conbriza

PMIDs:
15961563

Sources:
TdgClinicalTrial
CR 1447 ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta agonist

PMIDs:
None found

Sources:
ChemblInteractions
OSPEMIFENE ESR2

Interaction Score: 0.51

Interaction Types & Directionality:

modulator

Interaction Info:

Trial Name ospemifene,Ophena

Novel drug target Established target

Direct Interaction yes

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions
FULVESTRANT ESR2

Interaction Score: 0.39

Interaction Types & Directionality:

antagonist (inhibitory)

Interaction Info:

Notes

Mechanism of Interaction Estrogen receptor antagonist

Direct Interaction yes

PMIDs:
19845386

Sources:
TALC DTC ChemblInteractions PharmGKB
RALOXIFENE ESR2

Interaction Score: 0.38

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Novel drug target Established target

Trial Name -

PMIDs:
20659801 11810032 10418979 11861516 11752352 12097269 11500849

Sources:
DTC TdgClinicalTrial TEND PharmGKB
BAZEDOXIFENE ACETATE ESR2

Interaction Score: 0.34

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ESTRADIOL ESR2

Interaction Score: 0.34

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name Bio-E-Gel, estradiol,Elestrin

Novel drug target Established target

Trial Name drospirenone plus estradiol,Angeliq

PMIDs:
16520733 19561619 20659801 17464340 2011412 23882126 24971815

Sources:
DTC TdgClinicalTrial TEND
NARINGENIN ESR2

Interaction Score: 0.29

Interaction Types & Directionality:

partial agonist (activating)

Interaction Info:

PMIDs:
9751507

Sources:
TTD
TOREMIFENE ESR2

Interaction Score: 0.29

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name atamestane-plus-toremifene

PMIDs:
None found

Sources:
TdgClinicalTrial PharmGKB
IDOXIFENE ESR2

Interaction Score: 0.25

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
TAMOXIFEN ESR2

Interaction Score: 0.24

Interaction Types & Directionality:

agonist (activating)

antagonist (inhibitory)

Interaction Info:

Trial Name -

Novel drug target Established target

PMIDs:
17158759 16822624 20827267 2011412 16010412 17404078 11752352 16326830 17713466 20659801

Sources:
DTC TdgClinicalTrial TEND PharmGKB
QUINESTROL ESR2

Interaction Score: 0.2

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
CHLOROTRIANISENE ESR2

Interaction Score: 0.2

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor beta modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
DROLOXIFENE ESR2

Interaction Score: 0.17

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
ERIBULIN ESR2

Interaction Score: 0.17

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
GOSERELIN ESR2

Interaction Score: 0.17

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
AFIMOXIFENE ESR2

Interaction Score: 0.16

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
15846122

Sources:
ChemblInteractions
LETROZOLE ESR2

Interaction Score: 0.14

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
26536870

Sources:
PharmGKB
TOREMIFENE CITRATE ESR2

Interaction Score: 0.14

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
PERTUZUMAB ESR2

Interaction Score: 0.13

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
NERATINIB ESR2

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
CHEMBL600336 ESR2

Interaction Score: 0.09

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
GENISTEIN ESR2

Interaction Score: 0.08

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

PMIDs:
10592235 17016423 17139284

Sources:
TTD
ANASTROZOLE ESR2

Interaction Score: 0.08

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
EXEMESTANE ESR2

Interaction Score: 0.07

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
ABEMACICLIB ESR2

Interaction Score: 0.07

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
RIBOCICLIB ESR2

Interaction Score: 0.06

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
TRASTUZUMAB ESR2

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
IXABEPILONE ESR2

Interaction Score: 0.05

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
RALOXIFENE HYDROCHLORIDE ESR2

Interaction Score: 0.05

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor beta modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions
BITHIONOL ESR2

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
DTC
OLAPARIB ESR2

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
LAPATINIB ESR2

Interaction Score: 0.04

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
ALPELISIB ESR2

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
EVEROLIMUS ESR2

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
GEMCITABINE ESR2

Interaction Score: 0.03

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
22838950

Sources:
PharmGKB
PALBOCICLIB ESR2

Interaction Score: 0.02

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB
DOCETAXEL ESR2

Interaction Score: 0.01

Interaction Types & Directionality:

n/a

Interaction Info:

PMIDs:
None found

Sources:
PharmGKB

Ensembl: ENSG00000140009
- Version: 101_38
Alternate Names:

ESR2 Ensembl Gene Name

Gene Info:

Gene Biotype PROTEIN_CODING

Publications:
BaderLabGenes: ESR2
- Version: February-2014
Alternate Names:

2100 Entrez Gene ID

Gene Info:

Initial Gene Query NR3A2

Counted Citations from 1950-2000 3987

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:
RussLampel: ENSG00000140009
- Version: 26-July-2011
Alternate Names:

ESR2 Display Id

ESTROGEN RECEPTOR BETA (ER-BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q92731] Description

ENSG00000140009 Ensembl Gene Id

Gene Info:

Human Readable Name DRUGGABLE GENOME

Gene Categories:

DRUGGABLE GENOME

Publications:
HopkinsGroom: Q92731
- Version: 11-September-2012
Alternate Names:

ESR2 Uniprot Gene Name

ENSG00000140009 Ensembl Gene Id

2100 Entrez Gene Id

Gene Info:

Interpro Name Nuclear hormone receptor, ligand-binding, core

Human Readable Name DRUGGABLE GENOME

Human Readable Name NUCLEAR HORMONE RECEPTOR

Gene Categories:

NUCLEAR HORMONE RECEPTOR, DRUGGABLE GENOME

Publications:
TEND: Q92731
- Version: 01-August-2011
Alternate Names:

ENSG00000140009 Ensembl Gene Id

Q92731 Uniprot Accession

2100 Entrez Gene Id

Gene Info:

Target Subclass Nuclear receptor

Target Main Class Receptors

Publications:
TdgClinicalTrial: Q92731
- Version: January-2014
Alternate Names:

ESR2 Gene Symbol

Gene Info:

Target Class Receptors

Target Subclass Nuclear receptor

Publications:

PharmGKB: ESR2

Version: 18-August-2020

Alternate Names:

PA27886 PharmGKB ID

Gene Info:

Publications:

Ntukidem NI et al., 2008, Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen., Clin Pharmacol Ther

Woo HI et al., 2012, Effect of genetic polymorphisms on therapeutic response and clinical outcomes in pancreatic cancer patients treated with gemcitabine., Pharmacogenomics

Oesterreich S et al., 2015, Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover., Breast Cancer Res Treat

TTD: Estrogen receptor beta
- Version: 2020.06.01
Alternate Names:

ESR2 TTD Gene Abbreviation

T80896 TTD Target ID

Gene Info:

Publications:

Chollet JA, 2011, Update on alternative therapies for vulvovaginal atrophy., Patient Prefer Adherence

DTC: ESR2

Version: 02-September-2020

Alternate Names:

Gene Info:

Publications:

Calogeropoulou T et al., 2009, Novel dehydroepiandrosterone derivatives with antiapoptotic, neuroprotective activity., J Med Chem

Jain D et al., 2010, A mutant selective anti-estrogen is a pure antagonist on EREs and AP-1 response elements., Bioorg Med Chem Lett

Bologa et al., 2006, Virtual and biomolecular screening converge on a selective agonist for GPR30., Nat. Chem. Biol.

HingoraniCasas: ENSG00000140009
- Version: 31-May-2017
Alternate Names:

ENSG00000140009 Gene Symbol

ESR2 Ensembl Id

Gene Info:

Gene Categories:

DRUGGABLE GENOME

Publications:
TALC: ESR2
- Version: 12-May-2016
Alternate Names:

ESR2 Gene Symbol

Gene Info:

Publications:
ChemblInteractions: ESTRB
- Version: chembl_23
Alternate Names:

NR3A2 GENE_SYMBOL

ESR2 GENE_SYMBOL

Estrogen receptor beta UNIPROT

Gene Info:

Publications:
GO: ESR2
- Version: 01-February-2022
Alternate Names:

ESTRB GO Gene Synonym

NR3A2 GO Gene Synonym

Gene Info:

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:
dGene: ESR2
- Version: 27-Jun-2013
Alternate Names:

2100 Gene ID

ER-BETA dGene Synonym

ESR-BETA dGene Synonym

Gene Info:

Gene Categories:

NUCLEAR HORMONE RECEPTOR

Publications:
Pharos: ESR2
- Version: 01-February-2022
Alternate Names:

Estrogen receptor beta Gene Name

Q92731 UniProt ID

Gene Info:

Gene Categories:

NUCLEAR HORMONE RECEPTOR, TRANSCRIPTION FACTOR

Publications:

Direct Interaction	yes
Mechanism of Interaction	Estrogen receptor beta agonist
Trial Name	AUS-131

Trial Name	MF101 ,Menerba
Novel drug target	Established target
Mechanism of Interaction	Estrogen receptor beta agonist

Mechanism of Interaction	Estrogen receptor agonist
Direct Interaction	yes
Trial Name	MK-6913

Trial Name	conjugated estrogens/medroxyprogesterone acetate,Prempro, Premphase
Novel drug target	Established target
Trial Name	oral contraceptive,Pill-Plus

Trial Name	fispemifene, HM-101
Novel drug target	Established target
Mechanism of Interaction	Estrogen receptor modulator

Trial Name	ospemifene,Ophena
Novel drug target	Established target
Direct Interaction	yes

Notes
Mechanism of Interaction	Estrogen receptor antagonist
Direct Interaction	yes

Trial Name	Bio-E-Gel, estradiol,Elestrin
Novel drug target	Established target
Trial Name	drospirenone plus estradiol,Angeliq

Mechanism of Interaction	Estrogen receptor beta modulator
Direct Interaction	yes

ESR2	Display Id
ESTROGEN RECEPTOR BETA (ER-BETA). [SOURCE:UNIPROT/SWISSPROT;ACC:Q92731]	Description
ENSG00000140009	Ensembl Gene Id

ESR2	Uniprot Gene Name
ENSG00000140009	Ensembl Gene Id
2100	Entrez Gene Id

NR3A2	GENE_SYMBOL
ESR2	GENE_SYMBOL
Estrogen receptor beta	UNIPROT

ESR2 Gene Record

ESR2 2100 Druggable Genome

Alternate Names:

Gene Info:

Gene Categories: Category Details

Publications:

Interaction Types & Directionality: agonist (activating)

Interaction Info: Direct Interaction yes Mechanism of Interaction Estrogen receptor beta agonist Trial Name AUS-131

PMIDs: 15883431 15084758

Sources: TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor beta agonist Direct Interaction yes

PMIDs: 10592235

Sources: ChemblInteractions TTD

Interaction Types & Directionality: agonist (activating)

Interaction Info: Direct Interaction yes Mechanism of Interaction Estrogen receptor beta agonist

PMIDs: 10592235

Sources: ChemblInteractions TTD

Interaction Types & Directionality: agonist (activating)

Interaction Info: Trial Name MF101 ,Menerba Novel drug target Established target Mechanism of Interaction Estrogen receptor beta agonist

PMIDs: None found

Sources: TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 20659801 17139284 17016423 10592235

Sources: DTC

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: 23586645

Sources: DTC

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor agonist Direct Interaction yes Trial Name MK-6913

PMIDs: None found

Sources: TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info: Trial Name conjugated estrogens/medroxyprogesterone acetate,Prempro, Premphase Novel drug target Established target Trial Name oral contraceptive,Pill-Plus

PMIDs: None found

Sources: TdgClinicalTrial TTD

Interaction Types & Directionality: modulator

Interaction Info: Trial Name fispemifene, HM-101 Novel drug target Established target Mechanism of Interaction Estrogen receptor modulator

PMIDs: None found

Sources: TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality: allosteric modulator

Interaction Info:

PMIDs: 17109615 16806905 12209583

Sources: TTD

Interaction Types & Directionality: n/a

Interaction Info: Trial Name Evista Novel drug target Established target

PMIDs: None found

Sources: TdgClinicalTrial

Interaction Types & Directionality: modulator

Interaction Info: Direct Interaction yes Mechanism of Interaction Estrogen receptor modulator

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: modulator

Interaction Info: Mechanism of Interaction Estrogen receptor modulator Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor agonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor agonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor agonist Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: n/a

Interaction Info:

PMIDs: None found

Sources: TTD

Interaction Types & Directionality: modulator

Interaction Info: Mechanism of Interaction Estrogen receptor modulator Direct Interaction yes

PMIDs: None found

Sources: ChemblInteractions

Interaction Types & Directionality: agonist (activating)

Interaction Info: Mechanism of Interaction Estrogen receptor agonist Direct Interaction yes

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta agonist

Trial Name AUS-131

PMIDs:
15883431 15084758

Sources:
TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor beta agonist

Direct Interaction yes

PMIDs:
10592235

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor beta agonist

PMIDs:
10592235

Sources:
ChemblInteractions TTD

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Trial Name MF101 ,Menerba

Novel drug target Established target

Mechanism of Interaction Estrogen receptor beta agonist

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions TTD

Interaction Types & Directionality:

n/a

PMIDs:
20659801 17139284 17016423 10592235

Sources:
DTC

Interaction Types & Directionality:

n/a

PMIDs:
23586645

Sources:
DTC

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

Trial Name MK-6913

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name conjugated estrogens/medroxyprogesterone acetate,Prempro, Premphase

Novel drug target Established target

Trial Name oral contraceptive,Pill-Plus

PMIDs:
None found

Sources:
TdgClinicalTrial TTD

Interaction Types & Directionality:

modulator

Interaction Info:

Trial Name fispemifene, HM-101

Novel drug target Established target

Mechanism of Interaction Estrogen receptor modulator

PMIDs:
None found

Sources:
TdgClinicalTrial ChemblInteractions

Interaction Types & Directionality:

allosteric modulator

PMIDs:
17109615 16806905 12209583

Sources:
TTD

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name Evista

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

modulator

Interaction Info:

Direct Interaction yes

Mechanism of Interaction Estrogen receptor modulator

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

PMIDs:
None found

Sources:
TTD

Interaction Types & Directionality:

modulator

Interaction Info:

Mechanism of Interaction Estrogen receptor modulator

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

agonist (activating)

Interaction Info:

Mechanism of Interaction Estrogen receptor agonist

Direct Interaction yes

PMIDs:
None found

Sources:
ChemblInteractions

Interaction Types & Directionality:

n/a

Interaction Info:

Trial Name TAS-108

Novel drug target Established target

PMIDs:
None found

Sources:
TdgClinicalTrial

Interaction Types & Directionality:

n/a

Interaction Info:

Novel drug target Established target

Trial Name A-007

PMIDs:
None found

Sources:
TdgClinicalTrial